KURA ONCOLOGY LAUNCHES CASPIAN THERAPEUTICS WITH $50 MILLION FINANCING TO ADVANCE MENIN INHIBITION AS A POTENTIAL DISEASE-MODIFYING APPROACH FOR DIABETES

Reuters · 1d ago

Please log in to view news